SYS Systems sees dental boom with 350% sales growth
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
News and Insights of 3D Printing and Manufacturing
HomeMedical
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Want to speak at AMA: Energy 2025 or AMA: Automotive & Mobility 2025? Submit your application now!
Hong Kong based Centre for Immunology & Infection Limited (C2i), its spin-off C2iTech, and Japanese multinational conglomerate Hitachi have announced a strategic collaboration to develop 3D printed airway organoids for clinical applications. C2i also unveiled Hong Kong’s first automated organoid culture system, located at the Hong Kong Science Park (HKSTP). These joint efforts aim to enhance the efficiency, scalability, and standardization of organoid production, driving advancements in personalized medicine and regenerative therapies.
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense!
Secure your spot now for exclusive AM insights at our Additive Manufacturing Advantage online conference covering aerospace, space, and defense.
U.S.-based 3D printer manufacturer 3D Systems, in partnership with French MedTech firm TISSIUM, has secured FDA approval for a bioabsorbable, 3D printed device designed to treat peripheral nerve damage. This approval validates the polymer’s clinical effectiveness and paves the way for its use across a wide range of medical treatments.
Dimension Ortho, a provider of 3D printed orthotics, has entered into a partnership with Rothman Orthopaedics, a major U.S.-based orthopedic practice recognized for its work in musculoskeletal care. This collaboration will enable Rothman to implement Dimension Ortho’s platform for customized bracing and fracture care across its clinical network, with the goal of elevating patient care standards.
Ricoh USA, the North American arm of the Japanese digital services multinational, has announced the formation of Ricoh 3D for Healthcare, LLC, a new legal entity dedicated to delivering FDA-cleared, patient-specific 3D printed medical devices at hospitals across the United States. The company, unveiled on June 17, 2025, will enhance Ricoh’s ability to meet growing clinical demand for personalized care, streamline regulatory compliance, and support point-of-care manufacturing.
Researchers at Uppsala University in Sweden have developed 3D printed models from patient-derived cells to simulate motor neurons in the lab. These structures, known as motor neuron organoids, are expected to support research into neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS) and help explore treatment strategies without the need for invasive procedures.